Does TAFASITAMAB Cause Abdominal pain? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Abdominal pain have been filed in association with TAFASITAMAB (MONJUVI). This represents 0.7% of all adverse event reports for TAFASITAMAB.
9
Reports of Abdominal pain with TAFASITAMAB
0.7%
of all TAFASITAMAB reports
4
Deaths
9
Hospitalizations
How Dangerous Is Abdominal pain From TAFASITAMAB?
Of the 9 reports, 4 (44.4%) resulted in death, 9 (100.0%) required hospitalization, and 4 (44.4%) were considered life-threatening.
Is Abdominal pain Listed in the Official Label?
Yes, Abdominal pain is listed as a known adverse reaction in the official FDA drug label for TAFASITAMAB.
What Other Side Effects Does TAFASITAMAB Cause?
Disease progression (470)
Diffuse large b-cell lymphoma (346)
Off label use (203)
Death (146)
Neutropenia (99)
Covid-19 (96)
General physical health deterioration (75)
Pneumonia (66)
Febrile neutropenia (64)
Drug ineffective (62)
What Other Drugs Cause Abdominal pain?
ADALIMUMAB (10,983)
VEDOLIZUMAB (6,401)
INFLIXIMAB (6,059)
METHOTREXATE (5,002)
LEVONORGESTREL (4,054)
ACETAMINOPHEN (4,001)
PREDNISONE (3,704)
RITUXIMAB (3,364)
ETANERCEPT (2,524)
TOCILIZUMAB (2,485)
Which TAFASITAMAB Alternatives Have Lower Abdominal pain Risk?
TAFASITAMAB vs TAFASITAMAB-CXIX
TAFASITAMAB vs TAFINLAR
TAFASITAMAB vs TAFLUPROST
TAFASITAMAB vs TAGRAXOFUSP-ERZS
TAFASITAMAB vs TAHOR